LEO Pharma enhances dermatology pipeline with Timber Pharmaceuticals takeover 22-Aug-2023 By Isabel Cameron LEO Pharma has acquired Timber Pharmaceuticals, in a deal that will add an ‘attractive’ late stage asset to its pipeline in medical dermatology, the company said.
LEO partners for needle-free delivery of biologics 05-Dec-2019 By Ben Hargreaves LEO and Portal collaborate in the development of needle-free device to allow patient to self-administer dermatology products.
Leo to market AstraZeneca’s psoriasis treatment outside the EU 15-Aug-2019 By Vassia Barba Leo Pharma acquires exclusive rights to develop and market brodalumab, a treatment for psoriasis, outside of Europe.
LEO partners to reduce multi-hour dermatology treatments to seconds 11-Apr-2019 By Vassia Barba LEO and Elektrofi begin development of injectable dermatological drugs to replace infusions, reducing the amount of time required for treatment.